August 09, 2020
I did a brief on this last week, and on sober reconsideration, decided it was worth more than that. Steve Kirsch was sports editor of The Tech, and despite that has gone on to quite a career as an entrepreneur and philanthropist, with his own panel of expert scientific advisors. Best of all, he’s a guy who doesn’t get up in the morning without checking the best available science. You can look him up. He was interviewed on KCBS-AM (find it here, search for Covid Research). The whole interview is a good read; I recommend it. But as a content creator, I don’t like to reprint whole articles unless they seem in imminent danger of disappearing.
As the world awaits a corona virusvaccine in anticipation of returning to a "normal life," scientists are still seeking funding to find the most effective ways to treat the virus with existing drugs.
Steve Kirsch is the founder of COVID-19 Early Treatment Fund (CETF) [CLICK AND DONATE] and wanted to look at what's being done, and not being done, by talking to researchers he's helped fund over the years to try and find a way to treat the virus early as someone who faces multiple risk factors himself.
Kirsch said CETF needs $17 million more to test the eight different approaches it has identified for treatment.
One listener donated $200,000 after hearing the interview. There’s a stretch goal. If you donate more than $200,000 let me know!